Urocross Expander System (Prodeon Medical): FDA status

Approved Approved Mar 16, 2026. Indication: Lower urinary tract symptoms secondary to benign prostatic hyperplasia. Company: Prodeon Medical.

Regulatory history

All products in the FDA Tracker

Loading today's edition…